Q&A with David Loren: Managing Patients With Pancreatic Cystic Lesions

OCTOBER 19, 2015
Amy Jacob



David Loren, MD, Thomas Jefferson University, shares data on the molecular test PancraGen, which helps identify false negative cases that could be missed by first-line tests like imaging, cytology and fluid chemistry.
 
Loren commented, "We're trying to find those molecular markers. It's a completely different scientific approach to what we call the other types of what we call 'first-line' approach".


Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.